ProCE Banner Activity

ExpressPoints: Immune Checkpoint Inhibitors: Altering the Landscape of Treatment in Hepatobiliary Cancers

Slideset Download
Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.

Released: June 18, 2021

Expiration: June 17, 2022

No longer available for credit.

Share

Faculty

Lipika Goyal

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Kate MacDougall

Kate MacDougall

Amit G. Singal

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Kate MacDougall,

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas